Cargando…
A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis
(1) Objective: To describe the usefulness of a real-time therapeutic drug monitoring (TDM)-based strategy for optimizing pharmacokinetic/pharmacodynamic (PK/PD) target attainment of continuous infusion (CI) ampicillin-based regimens in a case series of patients affected by suspected or documented en...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404876/ https://www.ncbi.nlm.nih.gov/pubmed/36009906 http://dx.doi.org/10.3390/antibiotics11081037 |
_version_ | 1784773741643825152 |
---|---|
author | Gatti, Milo Tedeschi, Sara Trapani, Filippo Ramirez, Stefania Mancini, Rita Giannella, Maddalena Viale, Pierluigi Pea, Federico |
author_facet | Gatti, Milo Tedeschi, Sara Trapani, Filippo Ramirez, Stefania Mancini, Rita Giannella, Maddalena Viale, Pierluigi Pea, Federico |
author_sort | Gatti, Milo |
collection | PubMed |
description | (1) Objective: To describe the usefulness of a real-time therapeutic drug monitoring (TDM)-based strategy for optimizing pharmacokinetic/pharmacodynamic (PK/PD) target attainment of continuous infusion (CI) ampicillin-based regimens in a case series of patients affected by suspected or documented enterococcal bloodstream infections (BSIs) and/or infective endocarditis (IE). (2) Methods: Patients treated with CI ampicillin-based regimens for documented or suspected enterococcal BSI/IE who underwent real-time therapeutic drug monitoring (TDM)-based expert clinical pharmacological advice (ECPA) between June 2021 and May 2022 were retrospectively assessed. Ampicillin concentrations were determined at steady state, and the free fraction (fC(ss)) was calculated according to a plasma protein binding of 20%. The fC(ss)/MIC ratio was selected as the PD parameter for ampicillin efficacy and was defined as optimal for values between 4 and 8. The requirement for TDM-guided ampicillin dosing adjustments was assessed. (3) Results: Data for 12 patients with documented (n = 10) or suspected (n = 2) enterococcal infections (7 with BSIs and 5 with IE) were retrieved. The ampicillin PK/PD target was optimal over time in all of the 10 documented infections. None of the enterococcal BSIs persisted. Following the first real-time TDM-based ECPA, ampicillin dosage was decreased by >50% in 11 out of 12 patients (91.7%). (4) Conclusions: CI may be helpful in attaining aggressive ampicillin PK/PD targets in patients affected by enterococcal BSIs and/or IE. Administration of CI ampicillin after loading coupled with real-time TDM-based ECPA could be a valuable strategy for managing enterococcal infections. |
format | Online Article Text |
id | pubmed-9404876 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94048762022-08-26 A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis Gatti, Milo Tedeschi, Sara Trapani, Filippo Ramirez, Stefania Mancini, Rita Giannella, Maddalena Viale, Pierluigi Pea, Federico Antibiotics (Basel) Article (1) Objective: To describe the usefulness of a real-time therapeutic drug monitoring (TDM)-based strategy for optimizing pharmacokinetic/pharmacodynamic (PK/PD) target attainment of continuous infusion (CI) ampicillin-based regimens in a case series of patients affected by suspected or documented enterococcal bloodstream infections (BSIs) and/or infective endocarditis (IE). (2) Methods: Patients treated with CI ampicillin-based regimens for documented or suspected enterococcal BSI/IE who underwent real-time therapeutic drug monitoring (TDM)-based expert clinical pharmacological advice (ECPA) between June 2021 and May 2022 were retrospectively assessed. Ampicillin concentrations were determined at steady state, and the free fraction (fC(ss)) was calculated according to a plasma protein binding of 20%. The fC(ss)/MIC ratio was selected as the PD parameter for ampicillin efficacy and was defined as optimal for values between 4 and 8. The requirement for TDM-guided ampicillin dosing adjustments was assessed. (3) Results: Data for 12 patients with documented (n = 10) or suspected (n = 2) enterococcal infections (7 with BSIs and 5 with IE) were retrieved. The ampicillin PK/PD target was optimal over time in all of the 10 documented infections. None of the enterococcal BSIs persisted. Following the first real-time TDM-based ECPA, ampicillin dosage was decreased by >50% in 11 out of 12 patients (91.7%). (4) Conclusions: CI may be helpful in attaining aggressive ampicillin PK/PD targets in patients affected by enterococcal BSIs and/or IE. Administration of CI ampicillin after loading coupled with real-time TDM-based ECPA could be a valuable strategy for managing enterococcal infections. MDPI 2022-08-01 /pmc/articles/PMC9404876/ /pubmed/36009906 http://dx.doi.org/10.3390/antibiotics11081037 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gatti, Milo Tedeschi, Sara Trapani, Filippo Ramirez, Stefania Mancini, Rita Giannella, Maddalena Viale, Pierluigi Pea, Federico A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis |
title | A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis |
title_full | A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis |
title_fullStr | A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis |
title_full_unstemmed | A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis |
title_short | A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis |
title_sort | proof of concept of the usefulness of a tdm-guided strategy for optimizing pharmacokinetic/pharmacodynamic target of continuous infusion ampicillin-based regimens in a case series of patients with enterococcal bloodstream infections and/or endocarditis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404876/ https://www.ncbi.nlm.nih.gov/pubmed/36009906 http://dx.doi.org/10.3390/antibiotics11081037 |
work_keys_str_mv | AT gattimilo aproofofconceptoftheusefulnessofatdmguidedstrategyforoptimizingpharmacokineticpharmacodynamictargetofcontinuousinfusionampicillinbasedregimensinacaseseriesofpatientswithenterococcalbloodstreaminfectionsandorendocarditis AT tedeschisara aproofofconceptoftheusefulnessofatdmguidedstrategyforoptimizingpharmacokineticpharmacodynamictargetofcontinuousinfusionampicillinbasedregimensinacaseseriesofpatientswithenterococcalbloodstreaminfectionsandorendocarditis AT trapanifilippo aproofofconceptoftheusefulnessofatdmguidedstrategyforoptimizingpharmacokineticpharmacodynamictargetofcontinuousinfusionampicillinbasedregimensinacaseseriesofpatientswithenterococcalbloodstreaminfectionsandorendocarditis AT ramirezstefania aproofofconceptoftheusefulnessofatdmguidedstrategyforoptimizingpharmacokineticpharmacodynamictargetofcontinuousinfusionampicillinbasedregimensinacaseseriesofpatientswithenterococcalbloodstreaminfectionsandorendocarditis AT mancinirita aproofofconceptoftheusefulnessofatdmguidedstrategyforoptimizingpharmacokineticpharmacodynamictargetofcontinuousinfusionampicillinbasedregimensinacaseseriesofpatientswithenterococcalbloodstreaminfectionsandorendocarditis AT giannellamaddalena aproofofconceptoftheusefulnessofatdmguidedstrategyforoptimizingpharmacokineticpharmacodynamictargetofcontinuousinfusionampicillinbasedregimensinacaseseriesofpatientswithenterococcalbloodstreaminfectionsandorendocarditis AT vialepierluigi aproofofconceptoftheusefulnessofatdmguidedstrategyforoptimizingpharmacokineticpharmacodynamictargetofcontinuousinfusionampicillinbasedregimensinacaseseriesofpatientswithenterococcalbloodstreaminfectionsandorendocarditis AT peafederico aproofofconceptoftheusefulnessofatdmguidedstrategyforoptimizingpharmacokineticpharmacodynamictargetofcontinuousinfusionampicillinbasedregimensinacaseseriesofpatientswithenterococcalbloodstreaminfectionsandorendocarditis AT gattimilo proofofconceptoftheusefulnessofatdmguidedstrategyforoptimizingpharmacokineticpharmacodynamictargetofcontinuousinfusionampicillinbasedregimensinacaseseriesofpatientswithenterococcalbloodstreaminfectionsandorendocarditis AT tedeschisara proofofconceptoftheusefulnessofatdmguidedstrategyforoptimizingpharmacokineticpharmacodynamictargetofcontinuousinfusionampicillinbasedregimensinacaseseriesofpatientswithenterococcalbloodstreaminfectionsandorendocarditis AT trapanifilippo proofofconceptoftheusefulnessofatdmguidedstrategyforoptimizingpharmacokineticpharmacodynamictargetofcontinuousinfusionampicillinbasedregimensinacaseseriesofpatientswithenterococcalbloodstreaminfectionsandorendocarditis AT ramirezstefania proofofconceptoftheusefulnessofatdmguidedstrategyforoptimizingpharmacokineticpharmacodynamictargetofcontinuousinfusionampicillinbasedregimensinacaseseriesofpatientswithenterococcalbloodstreaminfectionsandorendocarditis AT mancinirita proofofconceptoftheusefulnessofatdmguidedstrategyforoptimizingpharmacokineticpharmacodynamictargetofcontinuousinfusionampicillinbasedregimensinacaseseriesofpatientswithenterococcalbloodstreaminfectionsandorendocarditis AT giannellamaddalena proofofconceptoftheusefulnessofatdmguidedstrategyforoptimizingpharmacokineticpharmacodynamictargetofcontinuousinfusionampicillinbasedregimensinacaseseriesofpatientswithenterococcalbloodstreaminfectionsandorendocarditis AT vialepierluigi proofofconceptoftheusefulnessofatdmguidedstrategyforoptimizingpharmacokineticpharmacodynamictargetofcontinuousinfusionampicillinbasedregimensinacaseseriesofpatientswithenterococcalbloodstreaminfectionsandorendocarditis AT peafederico proofofconceptoftheusefulnessofatdmguidedstrategyforoptimizingpharmacokineticpharmacodynamictargetofcontinuousinfusionampicillinbasedregimensinacaseseriesofpatientswithenterococcalbloodstreaminfectionsandorendocarditis |